Bookbuilding IPO | ₹1,952 Cr | Listed at BSE, NSE | Wed, Jul 3, 2024 - Fri, Jul 5, 2024
| Category | QIB | NII | Retail | Employees | Total | ||||
|---|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Below ₹10L | Above ₹10L | Total NII | ||||
| Allocation (No. of shares) | 38,53,234 | 57,79,850 | 96,33,084 | 9,63,308 | 19,26,618 | 28,89,926 | 67,43,160 | 1,08,900 | 1,93,75,070 |
| Allotment price (Rs.) | 1,008 | 1,008 | 1,008 | 1,008 | 1,008 | 1,008 | 1,008 | 918 | 1,007 |
| No.of applications | 233 | 48 | 281 | 1,66,140 | 1,00,107 | 2,66,247 | 24,82,655 | 3,074 | 27,52,257 |
| No.of shares applied | 73,55,18,588 | 57,79,850 | 74,12,98,438 | 3,67,69,166 | 10,54,36,184 | 14,22,05,350 | 4,87,62,504 | 2,46,932 | 93,25,13,224 |
| Amount collected (Rs.cr.) | 74,140.27 | 582.61 | 74,722.88 | 3,706.33 | 10,627.97 | 14,334.30 | 4,915.26 | 22.67 | 93,950.16 |
| No.of times subscribed | 190.88 | 1.00 | 76.95 | 38.17 | 54.73 | 49.21 | 7.23 | 2.27 | 48.13 |
| No.of shares allotted | 38,53,234 | 57,79,850 | 96,33,084 | 9,63,308 | 19,26,618 | 28,89,926 | 67,43,160 | 1,08,900 | 1,93,75,070 |
| Amount (Rs.cr.) | 388.41 | 582.61 | 971.01 | 97.10 | 194.20 | 291.30 | 679.71 | 10.00 | 1,952.03 |
| No.of allottees | 233 | 48 | 281 | 4,587 | 9,174 | 13,761 | 4,81,654 | 2,363 | 4,98,059 |
Emcure Pharmaceuticals IPO is a public issue of 1.94 Cr equity shares. The issue offers 0.67 Cr shares to retail investors, 0.96 Cr shares to qualified institutional buyers, and 0.29 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| QIB | 96,33,084 | 971.01 | 49.72% |
| Anchor | 57,79,850 | 582.61 | 29.83% |
| QIB (Ex Anchor) | 38,53,234 | 388.41 | 19.89% |
| NII | 28,89,926 | 291.30 | 14.92% |
| bNII (> ₹10L) | 19,26,618 | 194.20 | 9.94% |
| sNII (< ₹10L) | 9,63,308 | 97.10 | 4.97% |
| Retail | 67,43,160 | 679.71 | 34.80% |
| Employee | 1,08,900 | 10.98 | 0.56% |
| Total | 1,93,75,070 | 1,953.01 | 100% |
A total of 57,79,850 shares at a price of Rs 1,008 per share will be allotted to the anchor investors.
| Anchor investors bid opening date | Jul 02, 2024 |
| Anchor investor price | ₹1,008.00 |
| Anchor investors as % of QIBs | 60.00% |
| No. of shares locked-in for 30 days | 28,89,925 |
| No. of shares locked-in for 90 days | 28,89,925 |
📑 Anchor Investor Allotment Letter
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Emcure Pharmaceuticals IPO is subscribed 67.87 times by Jul 05, 2024 18:20.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 191.24 |
| Non Institutional | 49.32 |
| Retail Individual | 7.36 |
| Employee Reservations | 8.81 |
| Total Subscription | 67.87 |
An investor can apply in Emcure Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Emcure Pharmaceuticals IPO shares are offered online only.
The Emcure Pharmaceuticals IPO is subscribed 67.87 times by Jul 05, 2024 18:20.
The Emcure Pharmaceuticals IPO allotment status is expected on or around Monday, July 8, 2024. Visit Emcure Pharmaceuticals IPO allotment status to check.
The Emcure Pharmaceuticals IPO listing date is July 10, 2024. The equity share of Emcure Pharmaceuticals IPO will list on BSE, NSE.
Visit Emcure Pharmaceuticals IPO subscription status page for real-time bidding information about Emcure Pharmaceuticals IPO.
| IPO opens On | Wednesday, July 3, 2024 |
| IPO Closes On | Friday, July 5, 2024 |
| Finalisation of Basis of Allotment | Monday, July 8, 2024 |
| Initiation of Refunds | Tuesday, July 9, 2024 |
| Credit of Shares to Demat Account | Tuesday, July 9, 2024 |
| IPO Listing Date | Wednesday, July 10, 2024 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |